Allspring Global Investments
BBIO icon

Allspring Global Investments’s BridgeBio Pharma BBIO Stock Holding History

Allspring Global Investments’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.3M Sell
742,547
-146,809
-17% -$10.3M 0.08% 268
2026
Q1 		$66.2M Sell
889,356
-104,864
-11% -$7.6M 0.11% 221
2025
Q4 		$77.8M Buy
994,220
+987,273
+14,212% +$64.8M 0.13% 201
2025
Q3 		$372K Sell
6,947
-310
-4% -$15.1K ﹤0.01% 1421
2025
Q2 		$310K Sell
7,257
-353
-5% -$12.8K ﹤0.01% 1465
2025
Q1 		$251K Buy
+7,610
New +$257K ﹤0.01% 1617
2024
Q4 		– Sell
-5,322
Closed -$135K – 1816
2024
Q3 		$135K Buy
5,322
+801
+18% +$21K ﹤0.01% 1737
2024
Q2 		$115K Sell
4,521
-47
-1% -$1.28K ﹤0.01% 1823
2024
Q1 		$141K Buy
4,568
+385
+9% +$13.1K ﹤0.01% 1775
2023
Q4 		$169K Sell
4,183
-10,412
-71% -$313K ﹤0.01% 1720
2023
Q3 		$385K Sell
14,595
-313
-2% -$8.88K ﹤0.01% 1581
2023
Q2 		$256K Sell
14,908
-2,699
-15% -$40.6K ﹤0.01% 1729
2023
Q1 		$292K Buy
17,607
+3,184
+22% +$37.1K ﹤0.01% 1728
2022
Q4 		$110K Sell
14,423
-166
-1% -$1.59K ﹤0.01% 2039
2022
Q3 		$145K Buy
14,589
+2,091
+17% +$21.7K ﹤0.01% 1927
2022
Q2 		$113K Sell
12,498
-11,165
-47% -$93.4K ﹤0.01% 2014
2022
Q1 		$240K Sell
23,663
-1,491
-6% -$15.3K ﹤0.01% 2510
2021
Q4 		$419K Buy
+25,154
New +$1.06M ﹤0.01% 2370

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Allspring Global Investments's BBIO Position: Q2 2026 in Review

Allspring Global Investments reduced its BridgeBio Pharma (BBIO) stake by 17% in Q2 2026, selling an estimated $10.3M and leaving 742,547 shares worth $55.3M. The position accounts for 0.08% of the portfolio, ranked #268.

Allspring Global Investments first reported a position in BBIO in Q4 2021 and has held it in 18 quarters since. The position peaked at $77.8M in Q4 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Allspring Global Investments held 742,547 shares of BridgeBio Pharma worth $55.3M as of Q2 2026.
  • Allspring Global Investments sold 146,809 BridgeBio Pharma shares in Q2 2026, an estimated $10.3M.
  • BridgeBio Pharma made up 0.08% of Allspring Global Investments's portfolio in Q2 2026, its #268 holding.
  • Allspring Global Investments first reported a position in BridgeBio Pharma in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's BridgeBio Pharma position peaked at $77.8M in Q4 2025.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.